Morning Overview on MSN
GLP-1 drugs fail to slow Alzheimer’s in 2 major trials
Two of the most closely watched Alzheimer clinical trials of the decade have delivered a sobering verdict: GLP-1 drugs that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback